Labcorp Holdings Inc. (LH) EBITDA Margin: 14.43%
Is Labcorp Holdings Inc.’s EBITDA margin high or low?
Labcorp Holdings Inc.'s EBITDA margin of 14.43% is 19% below its 5-year average of 17.86%, near the low end of its 5-year range (11.10%–27.99%).
As of Sunday, June 14, 2026. 1.80% above its 12-month average of 14.18%.
LH EBITDA Margin Chart
LH Average EBITDA Margin Chart
LH Current vs Average EBITDA Margin Chart
LH EBITDA Margin Metrics
EBITDA MARGIN
14.43%
EBITDA MARGIN AVG TTM
14.18%
EBITDA MARGIN AVG 3Y
13.98%
EBITDA MARGIN AVG 5Y
17.86%
EBITDA MARGIN AVG 10Y
18.03%
EBITDA MARGIN AVG 15Y
19.16%
EBITDA MARGIN AVG 20Y
20.26%
CURRENT VS TTM AVG
+1.80%
CURRENT VS 3Y AVG
+3.22%
CURRENT VS 5Y AVG
-19.21%
CURRENT VS 10Y AVG
-19.97%
CURRENT VS 15Y AVG
-24.67%
CURRENT VS 20Y AVG
-28.78%
LH Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 14.43% | 14.18% | 13.98% | 17.86% |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 30.67% | 31.14% | 31.31% | 30.59% |
| BioNTech SE (BNTX) | $22.90B | -22.78% | -18.06% | 18.90% | 22.14% |
| United Therapeutics Corporation (UTHR) | $23.17B | 57.15% | 57.33% | 56.99% | 52.54% |
| Waters Corporation (WAT) | $23.17B | 31.97% | 33.50% | 33.77% | 33.93% |
| Moderna, Inc. (MRNA) | $19.80B | -131.33% | -118.72% | -58.16% | -40.65% |
| Veeva Systems Inc. (VEEV) | $25.92B | 37.38% | 36.14% | 30.88% | 30.08% |
| Hologic, Inc. (HOLX) | $16.97B | 24.97% | 28.56% | 32.04% | 36.42% |
| DexCom, Inc. (DXCM) | $29.08B | 29.14% | 26.30% | 24.33% | 22.05% |
| Biogen Inc. (BIIB) | $29.53B | 31.60% | 31.28% | 30.38% | 32.54% |
Margin Comparison
Gross Margin
27.8%
EBITDA Margin
14.4%
Operating Margin
11.0%
Net Margin
6.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Labcorp Holdings Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. EBITDA Margin FAQ
- What is the EBITDA margin for Labcorp Holdings Inc. (LH)?
- The EBITDA margin for LH stock is 14.43%.
- Is Labcorp Holdings Inc.'s EBITDA margin high or low?
- Labcorp Holdings Inc.'s EBITDA margin of 14.43% is 19% below its 5-year average of 17.86%, near the low end of its 5-year range (11.10%–27.99%).
- What is the TTM average EBITDA margin for Labcorp Holdings Inc. (LH)?
- The TTM average EBITDA margin for LH stock is 14.18%.
- What is the 3Y average EBITDA margin for Labcorp Holdings Inc. (LH)?
- The 3Y average EBITDA margin for LH stock is 13.98%.
- What is the 5Y average EBITDA margin for Labcorp Holdings Inc. (LH)?
- The 5Y average EBITDA margin for LH stock is 17.86%.
- What is the 10Y average EBITDA margin for Labcorp Holdings Inc. (LH)?
- The 10Y average EBITDA margin for LH stock is 18.03%.
- What is the 15Y average EBITDA margin for Labcorp Holdings Inc. (LH)?
- The 15Y average EBITDA margin for LH stock is 19.16%.
- What is the 20Y average EBITDA margin for Labcorp Holdings Inc. (LH)?
- The 20Y average EBITDA margin for LH stock is 20.26%.
Labcorp Holdings Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 14.43% |
| 2024-12-31 | 13.92% |
| 2023-12-31 | 11.10% |
| 2022-12-31 | 16.47% |
| 2021-12-31 | 27.99% |
| 2020-12-31 | 23.26% |
| 2019-12-31 | 18.32% |
| 2018-12-31 | 18.22% |
| 2017-12-31 | 17.68% |
| 2016-12-31 | 18.77% |
| 2015-12-31 | 18.17% |
| 2014-12-31 | 19.56% |
| 2013-12-31 | 21.32% |
| 2012-12-31 | 22.21% |
| 2011-12-31 | 21.31% |
| 2010-12-31 | 23.77% |
| 2009-12-31 | 24.30% |
| 2008-12-31 | 22.99% |
| 2007-12-31 | 24.34% |
| 2006-12-31 | 23.76% |
| 2005-12-31 | 23.58% |
| 2004-12-31 | 25.62% |
| 2003-12-31 | 22.74% |
| 2002-12-31 | 22.10% |
| 2001-12-31 | 21.44% |
| 2000-12-31 | 17.70% |
| 1999-12-31 | 13.79% |
| 1998-12-31 | 13.13% |
| 1997-12-31 | 1.15% |
| 1996-12-31 | 11.61% |
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter